FIBROBIOLOGICS INC. - COMMON STOCK
0.9050
07-May-25 16:45:00
15 minutes delayed
Stocks
+0.0141
+1.58%
Today's range
0.8600 - 0.9054
ISIN
N/A
Source
NASDAQ
-
FibroBiologics to Present at 2024 Cell & Gene Meeting on the Mesa
30 Sep 2024 09:31:00 By Nasdaq GlobeNewswire
-
FibroBiologics Engages Southern Star Research as CRO in Australia
19 Sep 2024 09:31:00 By Nasdaq GlobeNewswire
-
12 Sep 2024 09:31:00 By Nasdaq GlobeNewswire
-
FibroBiologics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
06 Sep 2024 09:31:00 By Nasdaq GlobeNewswire
-
20 Aug 2024 09:31:00 By Nasdaq GlobeNewswire
-
FibroBiologics Files 2024 Second Quarter Report
07 Aug 2024 18:52:58 By Nasdaq GlobeNewswire
-
FibroBiologics to Present at JonesTrading Healthcare Summit 2024
15 Jul 2024 09:31:00 By Nasdaq GlobeNewswire
-
25 Jun 2024 09:31:00 By Nasdaq GlobeNewswire
-
FibroBiologics Set to Join Russell 2000® Index
13 Jun 2024 09:31:00 By Nasdaq GlobeNewswire
-
FibroBiologics to Present at Extracellular Matrix Pharmacology Congress 2024
06 Jun 2024 09:31:00 By Nasdaq GlobeNewswire
-
FibroBiologics Announces 2024 Annual Meeting of Stockholders
15 May 2024 16:30:00 By Nasdaq GlobeNewswire
-
FibroBiologics Files 2024 First Quarter Report
14 May 2024 17:24:58 By Nasdaq GlobeNewswire
-
FibroBiologics to Present at the BIO International Convention 2024
07 May 2024 09:31:00 By Nasdaq GlobeNewswire
-
FibroBiologics Plans to Collaborate with Charles River to Manufacture Fibroblast-based Spheroids
25 Apr 2024 08:00:00 By Nasdaq GlobeNewswire
-
11 Apr 2024 09:31:00 By Nasdaq GlobeNewswire
-
04 Apr 2024 09:31:00 By Nasdaq GlobeNewswire
-
28 Mar 2024 09:31:00 By Nasdaq GlobeNewswire